More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Bharat Biotech International Limited on Thursday announced the launch of India’s only vertically integrated, purpose-designed Cell & Gene Therapy (CGT) Infrastructure and Viral Vector Production ...

Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of India's only vertically integrated, purpose ...

For decades, Bharat Biotech has led India’s effort in developing and manufacturing affordable vaccines for critical diseases. CGT aligns with BBIL’s broader vision of expanding beyond ...

Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...

Bharat Biotech International Limited (BBIL), has launched India’s only vertically integrated, purpose-designed cell & gene therapy (CGT) infrastructure & viral vector production facility at Genome ...

Shree Ganesh Biotech India Ltd share price was down by -1.05% from the previous closing price of ₹0.95. Who are peers of Shree Ganesh Biotech India Ltd? The peers of Shree Ganesh Biotech India ...

Bharat Biotech said it intends to focus more on the latter. India, compared to global peers, is still in the nascent stages of cell and gene therapy development with barely any adoption.

Indian aquaculture technology company Aquaconnect announced plans to invest USD 4.5 million (EUR 4.1 million) into the ...

The meeting, assisted by delegations from both sides, covered advancement in gene therapy, vaccine innovation, biotechnology manufacturing, and India’s evolving startup ecosystem. Dr. Singh emphasised ...

Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. A warm welcome to all my new ...